Analyzing The Cancer Genome Atlas (TCGA) [38], we found significantly lower CREBBP and EP300 expression in tumors of patients with colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) compared with matched nonmalignant tissues (Fig. S6A,B). The gene discussed is EP300; the disease is rectum adenocarcinoma.